NIH-funded research R01 grant

Understanding how heart cells mature for better heart function

Official title: Carm1-mediated transcriptional and posttranscriptional regulation of cardiomyocyte maturation

Funded at Univ of North Carolina Chapel Hill · NIH-11047363 · Data updated 2026-11-12

This study is looking at how heart cells grow and develop, especially focusing on a special enzyme called CARM1, to find ways to make these cells work better, which could help improve treatments for heart diseases.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniv of North Carolina Chapel Hill
NIH-funded
Lab location1 site (Chapel Hill, United States)
Project startJanuary 1, 2025
Project endNovember 30, 2028
Funding year2025
Award (this year)$751,747
NIH project number1R01HL168285-01A1
Project IDNIH-11047363 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with heart disease or conditions affecting heart function, particularly those under 21 years old.

Less likely to help

Patients with fully mature cardiomyocytes or those without any heart-related conditions may not benefit from this research.

What this research studies

This research investigates the maturation process of cardiomyocytes, the heart's primary cells responsible for contraction. It aims to identify the molecular and functional changes that occur in these cells during their development, particularly focusing on the role of a specific enzyme called CARM1. By studying how CARM1 influences cardiomyocyte maturation, the research seeks to uncover potential pathways that could enhance heart cell function, which is crucial for treating heart diseases. The findings could lead to improved strategies for regenerative medicine and heart disease management.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that enhance heart cell function and improve outcomes for patients with heart disease.

How similar studies have gone: Previous research has shown promising results in understanding cardiomyocyte maturation, but the specific role of CARM1 in this process is still largely untested.

Where this research is happening

  • Univ of North Carolina Chapel Hill
    Chapel Hill, United States
    Active

Researchers

  • Principal investigator: Liu, Jiandong — Univ of North Carolina Chapel Hill
  • Study coordinator: Liu, Jiandong

Related research

Other NIH-funded projects on the same topics.

  • A center for coordinating data related to heart and blood health.

    This study is working on a new system to gather and analyze health information about heart and blood disorders, which could lead to better ways to diagnose and treat these conditions, ultimately helping patients like you.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-9732880

  • Healthy work design and worker well-being

    A multi-site program aims to improve the health and well-being of workers by studying how work design affects safety, stress, and quality of life.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11631666

  • Unified and fair multimodal learning for autoimmune diseases

    A patient-friendly AI approach will combine many kinds of health data to improve diagnosis and personalized care for autoimmune diseases, including lupus.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11625649

  • Structural factors linking minimum wage, COVID-19, and community violence

    A long-term study will explore whether higher minimum wages and pandemic-related economic factors are connected to changes in violence in US communities.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11624218

  • Non-invasive tears biomarker for early Alzheimer's in LMICs

    A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11623923

  • How HPV interacts with our cells' DNA damage system and its effect on cancer

    This project looks at how high-risk HPV uses the body’s DNA repair machinery to replicate and potentially drive cancer, with the goal of finding new antiviral and cancer-fighting approaches for people affected by HPV-related diseases.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11622604

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.